Teva- Pharmaceutical Industries (TEVA) earnings, Nov 3, 2026: EPS +10%, stock +3.0%
In brief
Teva- Pharmaceutical Industries reported on Nov 3, 2026. Earnings per share changed +10% year over year, 19.3% above the estimate; revenue −2%. The stock opened with a +3.0% gap and closed the day +3.0% (Nov 3, 2026). The stock is now 2.2% below its 52-week high, +74.8% over 12 months. Next report: Feb 10, 2027.
EPS vs estimate+19.3%
EPS, YoY+10%
Revenue, YoY−2%
Gap · day+3.0% · +3.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | +6.3% | +9.6% |
| Nov 3, 2026 | +3.0% | +3.0% |
Next-quarter estimates, ratings and the TEVA chart are in the terminal.
Open the terminalFAQ
When is Teva- Pharmaceutical Industries's next earnings report?
Feb 10, 2027. The date comes from daily data and is corrected if the company moves it.
How did Teva- Pharmaceutical Industries stock react to the report?
Opening gap +3.0%, day's result +3.0%.
Did Teva- Pharmaceutical Industries's earnings grow?
Earnings per share rose 10% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.